Risk factors for motor complications in female patients with Parkinson's disease

Neurol Sci. 2022 Aug;43(8):4735-4743. doi: 10.1007/s10072-022-05959-3. Epub 2022 Apr 6.

Abstract

Objective: To investigate the risk factors of motor complications in female patients with Parkinson's disease (PD) and the correlation between the occurrence of motor complications and sex hormone levels.

Methods: According to the occurrence and types of motor complications, 103 female PD patients were divided into two groups: patients with or without the wearing-off phenomenon, patients with or without dyskinesia. Binary logistic regression analysis was performed respectively to screen for the risk factors of the wearing-off phenomenon and dyskinesia in female PD patients.

Results: Among 103 female PD patients, 44 (42.72%) had motor complications. Patients with the wearing-off phenomenon and patients with dyskinesia had higher prolactin levels than patients without the wearing-off phenomenon and patients without dyskinesia, respectively. However, the difference was no longer significant when the two groups were corrected for multiple comparisons (P < 0.0028). Multivariate analysis found that younger age at onset and higher Hoehn-Yahr (H&Y) stage were identified as independent risk factors for the wearing-off phenomenon and younger age of onset was an independent risk factor for dyskinesia in female PD patients (P < 0.05).

Conclusion: Female PD patients have a higher incidence of motor complications. Younger age of onset and higher H&Y stage were the risk factors of the wearing-off phenomenon, and younger onset age was the risk factor of dyskinesia in female PD patients. There may be a certain correlation between the occurrence of motor complications and sex hormone levels in female PD patients, which requires further verification.

Keywords: Dyskinesia; Female; Parkinson’s disease; Risk factors; Sex hormone; Wearing-off phenomenon.

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Dyskinesias* / epidemiology
  • Dyskinesias* / etiology
  • Female
  • Humans
  • Levodopa / adverse effects
  • Multivariate Analysis
  • Parkinson Disease* / complications
  • Parkinson Disease* / epidemiology
  • Risk Factors

Substances

  • Antiparkinson Agents
  • Levodopa